• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Watts Water Technologies Names Ryan Lada as Chief Financial Officer

    7/14/25 9:00:00 AM ET
    $GE
    $IEX
    $MDT
    $WTS
    Consumer Electronics/Appliances
    Technology
    Fluid Controls
    Industrials
    Get the next $GE alert in real time by email

    Watts Water Technologies, Inc. (NYSE:WTS) today announced that Ryan Lada has been appointed Chief Financial Officer effective July 28, 2025. Mr. Lada succeeds current Chief Financial Officer Shashank Patel, who previously announced his intent to retire in October 2024.

    Mr. Lada joins Watts from The AZEK Company, where he most recently served as Senior Vice President, Chief Financial Officer and Treasurer and was responsible for overseeing AZEK's enterprise-wide financial operations, overall financial and capital allocation strategy, and investor relations efforts. Mr. Lada departed AZEK on July 11, 2025 following its acquisition by James Hardie Industries.

    Chief Executive Officer, President and Chair of the Board, Robert J. Pagano, Jr. said, "We are excited to welcome Ryan to Watts as our next CFO. Ryan brings a track record for driving performance at leading global manufacturing companies and delivering exceptional results. He is a proven leader offering strong financial acumen, strategic vision, global M&A experience, and operating rigor. We are confident that Ryan will be a key contributor in helping us capitalize on profitable growth opportunities, navigate global market dynamics, and deliver sustained value to our stockholders."

    Mr. Lada previously held the role of Vice President of Corporate Finance and Chief Financial Officer of AZEK's Residential and Commercial segments. Before joining AZEK, he held several senior finance roles of increasing responsibility with Cantel Medical Corporation, including Vice President of Investor Relations and Treasury, Chief Financial Officer of the Global Medical Division and Chief Financial Officer for the Europe, Middle East and Africa region. Earlier in his career, Mr. Lada held financial leadership positions at General Electric Company (NYSE:GE), IDEX Corporation (NYSE:IEX) and Medtronic, Inc. (NYSE:MDT), building a strong foundation in public company operational finance, corporate development, and global financial planning. Mr. Lada earned a Six Sigma Black Belt certification in finance while at GE and holds a Bachelor of Science degree in Finance from The Black School of Business at Pennsylvania State University.

    Mr. Lada commented, "Watts impressed me with its iconic portfolio of global brands, strong 150+ year heritage and culture, and track record of innovation and growth in support of water efficiency, safety, and delivery. I am excited by the opportunity to partner with Bob and the team to help shape Watts' next chapter of profitable growth and deliver stakeholder value through financial vision and execution, strategic capital deployment, and commercial and operational excellence."

    Mr. Pagano concluded, "On behalf of our entire organization, I would like to also extend my gratitude to Shashank for his partnership, dedication, and impactful contributions over his seven years with Watts and for his willingness to provide extended assistance in transitioning his responsibilities to Ryan to ensure a seamless succession. We wish Shashank the very best on his well-earned retirement."

    About Watts Water Technologies, Inc.

    Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com.

    This press release includes "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995, including statements relating to capitalizing on growth opportunities, navigating turbulent market dynamics, realizing cost savings and delivering sustained value to our stockholders. These forward-looking statements reflect our current views about future events. You should not rely on forward-looking statements because our actual results may differ materially from those predicted as a result of a number of potential risks and uncertainties. These potential risks and uncertainties include, but are not limited to: the imposition of or changes to tariff rates; the effectiveness, timing and expected savings associated with our cost-cutting actions, restructuring and initiatives; integration of acquired businesses in a timely and cost-effective manner, retention of supplier and customer relationships and key employees, and the ability to achieve synergies and cost savings in the amounts and within the time frames currently anticipated; current economic and financial conditions, which can affect the housing and construction markets where our products are sold, manufactured and marketed; shortages in and pricing of raw materials and supplies; our ability to compete effectively; changes in variable interest rates on our borrowings; inflation; failure to expand our markets through acquisitions; failure to successfully develop and introduce new product offerings or enhancements to existing products; failure to manufacture products that meet required performance and safety standards; foreign exchange rate fluctuations; cyclicality of industries where we market our products, such as plumbing and heating wholesalers and home improvement retailers; environmental compliance costs; product liability risks and costs; changes in the status of current litigation; the war in Ukraine and other global crises; supply chain and logistical disruptions or labor shortages and workforce disruptions that could negatively affect our supply chain, manufacturing, distribution, or other business processes; and other risks and uncertainties discussed under the heading "Item 1A. Risk Factors" and in Note 16 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission ("SEC"), as well as risk factors disclosed in our subsequent filings with the SEC. We undertake no duty to update the information contained in this press release, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250714797715/en/

    Watts Water Technologies, Inc.

    Diane McClintock

    Senior Vice President FP&A and Investor Relations

    Telephone: 978-689-6153

    Email: [email protected]

    Get the next $GE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GE
    $IEX
    $MDT
    $WTS

    CompanyDatePrice TargetRatingAnalyst
    Watts Water Technologies Inc.
    $WTS
    9/19/2025$287.00Equal Weight
    Barclays
    Medtronic plc.
    $MDT
    6/30/2025Underperform → Peer Perform
    Wolfe Research
    Medtronic plc.
    $MDT
    6/16/2025$110.00Outperform
    Leerink Partners
    GE Aerospace
    $GE
    5/19/2025Buy → Neutral
    Northcoast
    Watts Water Technologies Inc.
    $WTS
    5/16/2025Buy → Neutral
    Northcoast
    Watts Water Technologies Inc.
    $WTS
    4/16/2025$229.00Hold → Buy
    Stifel
    GE Aerospace
    $GE
    4/9/2025$205.00Neutral → Buy
    Northcoast
    Medtronic plc.
    $MDT
    3/4/2025$92.00 → $107.00Neutral → Buy
    Citigroup
    More analyst ratings

    $GE
    $IEX
    $MDT
    $WTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Helmkamp Katrina L bought $399,026 worth of shares (2,500 units at $159.61), increasing direct ownership by 23% to 13,200 units (SEC Form 4)

    4 - IDEX CORP /DE/ (0000832101) (Issuer)

    8/11/25 4:22:26 PM ET
    $IEX
    Fluid Controls
    Industrials

    $GE
    $IEX
    $MDT
    $WTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

    TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first closed-loop DBS system for people with Parkinson's – has been recognized by TIME on its annual list of Best Inventions. There are over 10 million people living with Parkinson's disease globally,1 and while there is currently no cure, Medtronic deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other neurological disorders for more than 30 years. Medtronic recently enhanced its Percept™ DBS

    10/9/25 10:10:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

    Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart diseaseOrchestra BioMed and Medtronic (NYSE:MDT) have a strategic collaboration to develop and commercialize AVIM Therapy for the treatment of uncontrolled hypertension in patients indicated for a pacemaker, an estimated global population of over 750,000 patients annuallyAVIM Therapy has received FDA Breakthrough Device Designation for the treatment of uncontrolled hypertension in patients with increased cardiovascular risk, an estimated U.S. population of over 7.7 million patients NEW HOPE, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Orches

    10/9/25 8:00:00 AM ET
    $MDT
    $OBIO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medicinal Chemicals and Botanical Products

    Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures

    First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of its Hugo™ robotic-assisted surgery (RAS) system in robotic-assisted gynecological procedures. The first procedures, total hysterectomies, were successfully completed at AHN West Penn Hospital in Pittsburgh, PA, by Dr. Sarah Crafton and Dr. Eirwen Miller, Embrace Gynecology study

    10/8/25 7:00:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Bazin Sebastien

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    10/2/25 4:10:24 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form 4 filed by Director Angel Stephen F

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    10/2/25 4:10:16 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    EVP & President Cardiovascular Kiil Harry Skip sold $788,048 worth of Ordinary Shares (8,605 units at $91.58), decreasing direct ownership by 19% to 35,615 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    9/5/25 4:18:13 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    SEC Filings

    View All

    GE Aerospace filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - GENERAL ELECTRIC CO (0000040545) (Filer)

    10/1/25 6:33:18 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form 25-NSE filed by Medtronic plc.

    25-NSE - Medtronic plc (0001613103) (Subject)

    9/29/25 10:44:27 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form CERT filed by Medtronic plc.

    CERT - Medtronic plc (0001613103) (Filer)

    9/29/25 9:53:17 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Watts Water Tech. with a new price target

    Barclays initiated coverage of Watts Water Tech. with a rating of Equal Weight and set a new price target of $287.00

    9/19/25 8:40:08 AM ET
    $WTS
    Metal Fabrications
    Industrials

    Medtronic upgraded by Wolfe Research

    Wolfe Research upgraded Medtronic from Underperform to Peer Perform

    6/30/25 7:56:30 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Leerink Partners initiated coverage on Medtronic with a new price target

    Leerink Partners initiated coverage of Medtronic with a rating of Outperform and set a new price target of $110.00

    6/16/25 7:51:25 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Leadership Updates

    Live Leadership Updates

    View All

    GE AEROSPACE AND BETA TECHNOLOGIES PARTNER TO ADVANCE HYBRID ELECTRIC FLIGHT

    Companies to co-develop hybrid electric turbogenerator for defense and civil applications, enabling U.S. Advanced Air MobilityHybrid electric capabilities enable longer range, higher speed, lower operating cost and higher payload compared to other aircraft in the same segmentGE Aerospace to make an equity investment of $300 million in BETA Technologies, Inc.CINCINNATI, Sept. 4, 2025 /PRNewswire/ -- GE Aerospace (NYSE:GE) and BETA Technologies Inc. ("BETA") announced today a new strategic partnership and equity investment agreement, subject to regulatory approval, to accelerate the development of hybrid electric aviation by combining BETA's rapid innovation approach with GE Aerospace's global

    9/4/25 6:20:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Financials

    Live finance-specific insights

    View All

    IDEX Corporation Announces Increase to Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend

    IDEX Corporation (NYSE:IEX) announced today that its Board of Directors has increased the Company's share repurchase authorization, bringing total repurchase capacity to $1 billion from approximately $440 million remaining as of June 30, 2025. "This announcement highlights the confidence we have in our growth strategy and underscores our proven ability to consistently generate strong free cash flow. For the full year 2025, we expect to return at least 70% of free cash flow to shareholders through dividends and share repurchases. We plan to take a dynamic approach to capital allocation as we invest in growth opportunities that position IDEX for continued value creation and success," said E

    9/18/25 4:52:00 PM ET
    $IEX
    Fluid Controls
    Industrials

    GE Aerospace Board of Directors Authorizes Regular Quarterly Dividend

    CINCINNATI, Sept. 18, 2025 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.36 per share dividend on the outstanding common stock of the Company. The dividend is payable October 27, 2025, to shareholders of record at the close of business on September 29, 2025. The ex-dividend date is September 29, 2025. About GE AerospaceGE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 49,000 commercial and 29,000 military aircraft engines. With a global team of approximately 53,00

    9/18/25 1:30:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Medtronic reports first quarter fiscal 2026 financial results

    11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organicGAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidanceCardiac Ablation Solutions revenue increased nearly 50%, incl

    8/19/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $GE
    $IEX
    $MDT
    $WTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE Aerospace

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    11/12/24 12:54:20 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Amendment: SEC Form SC 13G/A filed by Watts Water Technologies Inc.

    SC 13G/A - WATTS WATER TECHNOLOGIES INC (0000795403) (Subject)

    11/5/24 3:09:24 PM ET
    $WTS
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13G/A filed by IDEX Corporation

    SC 13G/A - IDEX CORP /DE/ (0000832101) (Subject)

    10/7/24 1:03:55 PM ET
    $IEX
    Fluid Controls
    Industrials